Загрузка...
Exploring N(1)-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
Developing a single selective ligand to a target relevant to two mechanistically interlinked diseases, such as type 2 diabetes mellitus (T2DM) and a neurodegenerative disorder, like Parkinson's disease or Alzheimer's disease, provides the potential for an effective treatment that may impac...
Сохранить в:
| Опубликовано в: : | CNS Neurol Disord Drug Targets |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807432/ https://ncbi.nlm.nih.gov/pubmed/24059322 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|